Naltrexone and alcohol dependence: Role of subject compliance

Archives of General Psychiatry

Volumn 54, Issue 8, 1997, Pages 737-742

  Volpicelli, Joseph R ^a,b,d   Rhines, Karen C ^c   Rhines, Jared S ^a,b   Volpicelli, Laura A ^a,b   Alterman, Arthur I ^a,b   O'Brien, Charles P ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c RUTGERS UNIVERSITY   (United States)

^d Treatment Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; NALTREXONE; PLACEBO;

ADULT; ALCOHOL ABUSE; ALCOHOLISM; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRINKING BEHAVIOR; DRUG EFFICACY; DRUG INDUCED DISEASE; FEMALE; HUMAN; LIBIDO; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PATIENT COUNSELING; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0030860547     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.1997.01830200071010     Document Type: Article

References (26)

1. O'Malley SS, Jaffe AJ, Chang G, Schottenfeld RS, Meyer RE, Rounsaville B. Naltrexone and coping skills therapy for alcohol dependence: a controlled study. Arch Gen Psychiatry. 1992;49:881-887.
2. Volpicelli JR, Alterman AI, Hayashida M, O'Brien CP. Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry. 1992;49:876-880.
3. Volpicelli JR, Clay KL, Watson NT, O'Brien CP. Naltrexone in the treatment of alcoholism: predicting response to naltrexone. J Clin Psychiatry. 1995;56:39-44.
4. Volpicelli JR, O'Brien CP, Alterman Al, Hayashida M. Naltrexone and the treatment of alcohol dependence: initial observations. In: Reid L, ed. Opioids, Bulimia, and Alcohol Abuse & Alcoholism. New York, NY: Springer-Verlag; 1990: 195-214.
5. Altshuler HL, Phillips PE, Feinhandler DA. Alterations of ethanol self-administration by naltrexone. Life Sci. 1980;26:679-688.
6. Myers RD, Borg S, Mossberg R. Antagonism by naltrexone of voluntary alcohol selection in the chronically drinking macaque monkey. Alcohol. 1986;6:383-388.
7. Kornet M, Goosen C, Van Ree JM. Effect of naltrexone on alcohol consumption during chronic alcohol drinking and after a period of imposed abstinence in free-choice drinking rhesus monkeys. Psychopharmacology. 1991;104:367-376.
8. Le AD, Poulos CX, Quan B, Chow S. The effects of selective blockade of delta and mu opiate receptors on ethanol consumption by C57BL/6 mice in a restricted access paradigm. Brain Res. 1993;630:330-332.
9. Hubbell CL, Czirr SA, Hunter GA, Beaman CM, LeCann NC, Reid LD. Consumption of ethanol solution is potentiated by morphine and attenuated by naloxone persistently across repeated daily administrations. Alcohol. 1986;2(6):1-16.
10. Froehlich JC, Harts J, Lumeng L, Li TK. Naloxone attenuates voluntary ethanol intake in rats selectively bred for high ethanol preference. Pharmacol Biochem Behav. 1990;35:385-390.
11. Volpicelli JR, Davis MA, Olgin JE. Naltrexone blocks the post-shock increase of ethanol consumption. Life Sci. 1986;38:841-847.
12. Swift RM, Whelihan W, Kuznetsov O, Buongiorno G, Hsuing H. Naltrexone-induced alterations in human ethanol intoxication. Am J Psychiatry. 1994;151: 1463-1467.
13. Volpicelli JR, Watson NT, King AC, Sherman CE. Effect of naltrexone on alcohol 'high' in alcoholics. Am J Psychiatry. 1995;152:613-615.
14. O'Malley SS, Jaffe AJ, Rode S, Rounsaville BJ. Experience of a 'slip' among alcoholics treated with naltrexone or placebo. Am J Psychiatry. 1996;153:281-283.
15. Kleber HD, Kosten TR. Naltrexone induction: psychologic and pharmacologic strategies. J Clin Psychiatry. 1984;45(9):29-38.
16. Kosten TR, Kleber HD. Strategies to improve compliance with narcotic antagonists. Am J Drug Alcohol Abuse. 1984;10:249-266.
17. Greenstein RA, Arndt IC, McLellan AT, O'Brien CP, Evans B. Naltrexone: a clinical perspective. J Clin Psychiatry. 1984;45:25-28.
18. Greenstein RA, O'Brien CP, McLellan AT, Woody GE, Grabowski J, Long M, Coyle-Perkins G, Vittor A. Naltrexone: a short-term treatment for opiate dependence. Am J Drug Alcohol Abuse. 1981;8:291-300.
19. O'Brien CP, Volpicelli LA, Volpicelli JR. Naltrexone in the treatment of alcoholism: a clinical review. Alcohol. 1996;13:35-39.
20. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised. Washington, DC: American Psychiatric Association; 1987.
21. Gorski TT, Miller MM. Staying Sober: Guide to Relapse Prevention. Independence, Mo: Herald House; 1986.
22. Derogatis LR, Lipman RS, Rickels K. The Hopkins Symptom Checklist (HSCL): a self-report symptom inventory. Behav Sci. 1974;19:1-15.
23. Miller RG Jr. Survival Analysis. New York, NY: John Wiley & Sons Inc; 1981.
24. Mantel N. Chi-square tests with one degree of freedom: extensions of the Mantel-Haenszel procedure. Am Stat Assoc J. 1963;58:690-700.
25. Urquhart J. Ascertaining how much compliance is enough with outpatient antibiotic regimens. Postgrad Med J. 1992;68:S49-S59.
26. Cramer JA, Mattson RH, Prevey ML, Scheyer RD, Ouellette VL. How often is medication taken as prescribed? a novel assessment technique. JAMA. 1989;261: 3273-3277.